Fitxa persona

MARIA JOSE HERRERO CERVERA
PDI-Ajudant Doctor/A

maria.jose.herrero@uv.es

Àrea de coneixement: FARMACOLOGIA
Departament: Farmacologia

963864621

Publicacions en revistes

Olivera,G; Sendra, L; Herrer,M.J; Puig,C; Aliño, S. F (2019) Colorectal Cancer:pharmacogenetics support for the correct drug prescription. Pharmacogenomics, 20(10), pp. 741 - 763 . ISSN: 1462-2416
Sendra,L;Herrero,M.L; Montalvá,E;Noguera,I;Orbis,F;Diaz,A;Fernández-Delgado,R; López-Andujar; Aliño,S (2019) Efficacy Of interleukin 10 gene hydrofection in pig liver vascular isolated ´in vivo ´by surgical procedure with interest in liver transplantation. Plos One, 14(10), pp. 1 - 13 . ISSN: 1932-6203
Olivera,G;Sendra,L;Herrero,M.J:Berlanga,P;Gargallo,P;Yáñez,Y;Urtasun,A;Font de Mora,J; Castel,V;Cañete,A;Aliño, S.F (2019) Parmacogenetics Implementation in the clinics: information and guidelines for germline variants. Cancer Drug Resist. ISSN: 2578-532X
Gladys G Olivera; Yania Yáñez; Pablo Gargallo; Luis Sendra; Salvador F Aliño; Vanessa Segura; Miguel Ángel Sanz; Adela Cañete; Victoria Castel; Jaime Font De Mora; David Hervás; Pablo Berlanga; María José Herrero (2020) MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients. International Journal Of Molecular Sciences, 21 . ISSN: 1661-6596
Alexander Batista-Duharte; Luis Sendra; Maria José Herrero; Damiana Téllez-Martínez; Iracilda Zeppone Carlos; Salvador Francisco Aliño (2020) Progress In the use of antisense oligonucleotides for vaccine improvement. Biomolecules, 10, p. 316 . ISSN: 2218-273X
Luis Sendra; Antonio Miguel; M Carmen Navarro-Plaza; María José Herrero; José de la Higuera; Consuelo Cháfer-Pericás; Elena Aznar; M Dolores Marcos; Ramón Martínez-Máñez; Luis Alfonso Rojas; Ramón Alemany; Salvador F Aliño (2020) Gold Nanoparticle-Assisted Virus Formation by Means of the Delivery of an Oncolytic Adenovirus Genome. Nanomaterials, 10(6), p. 1183 . ISSN: 2079-4991
Fabiana Dalla Vecchia Genvigir , Antony Brayan Campos-Salazar, Claudia Rosso Felipe , Helio Tedesco-Silva Jr, José Osmar Medina-Pestana, Sonia de Quateli Doi, Alvaro Cerda, Mario Hiroyuki Hirata, María José Herrero, Salvador Francisco Aliño, Rosario Dominguez Crespo Hirata (2020) CYP3A5*3 and CYP2C8*3 Variants Influence Exposure and Clinical Outcomes of Tacrolimus-Based Therapy. Pharmacogenomics, 21(1), pp. 7 - 21 . ISSN: 1462-2416
Corallo D; Zanon C; Pantile M; Tonini GP; Zin A, Francescato S; Rossi B; Trevisson E; Pinato C; Monferrer E; Noguera R; Aliño SF; Herrero MJ; Biffi A; Viscardi E; Aveic S. (2021) Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study. Cells, 10(10), p. 2695 . ISSN: 2073-4409
Olivera G; Urtasun A; Sendra L; Aliño S; Yañez Y; Segura V; Gargallo P; Berlanga P; Castel V; Cañete A; Herrero MJ (2021) Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?. International Journal Of Molecular Sciences, 22(18), p. 9815 . ISSN: 1661-6596
Sanmartín I, Sendra L, Moret I, Herrero MJ, Aliño SF (2021) Multicompartmental Lipopolyplex as vehicle for antigens and genes delivery in vaccine formulations. Pharmaceutics, 13(2), p. 281 . ISSN: 1999-4923
Sendra L, García-Mares A, Herrero MJ, Aliño SF. (2021) Mitochondrial DNA replacement techniques to prevent human mitochondrial diseases. International Journal Of Molecular Sciences, 22(2), p. 551 . ISSN: 1661-6596
Megías-Vericat JE, Martínez-Cuadrón D, Herrero MJ, Rodríguez-Veiga R,Solana-Altabella A, Boluda B, Ballesta-López O, Cano I, Acuña-Cruz E, Cervera J, Poveda JL, Sanz MA, Aliño SF, Montesinos P (2021) Impact of combinations of Single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia. Leukemia & Lymphoma, 62(3), pp. 659 - 668 . ISSN: 1042-8194
Batista-Duharte A, Sendra L, Herrero MJ, Portuondo DL, Téllez-Martínez D, Olivera G, Fernández-Delgado M, Javega B, Herrera G, Martínez A, Costa PI, Zeppone Carlos I, Aliño SF (2021) Foxp3 Silencing with Antisense Oligonucleotide Improves Immunogenicity of an Adjuvanted Recombinant Vaccine against Sporothrix schenckii. International Journal Of Molecular Sciences, 22(7), p. 3470 . ISSN: 1661-6596
Megías-Vericat JE, Martínez-Cuadrón D, Herrero MJ, Rodríguez-Veiga R, Solana-Altabella A, Boluda B, Ballesta-López O, Cano I, Acuña-Cruz E, Cervera J, Poveda JL, Sanz MÁ, Aliño SF, Montesinos P. (2021) Influence of Polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia. Pharmacogenetics And Genomics, 31(6), pp. 133 - 139 . ISSN: 1744-6872
Cruz R, Diz-de Almeida S, López de Heredia M, Quintela I, Ceballos FC, Pita G, Lorenzo-Salazar JM, González-Montelongo R, Gago-Domínguez M, Sevilla Porras M, Tenorio Castaño JA, Nevado J, Aguado JM, Aguilar C, Aguilera-Albesa S, Almadana V, Almoguera B, Alvarez N, Andreu-Bernabeu Á, Arana-Arri E, Arango C, Arranz MJ, Artiga MJ, Baptista-Rosas RC, Barreda-Sánchez M, Belhassen-Garcia M, Bezerra JF, Bezerra MAC, et al. (2022) Novel genes and sex differences in COVID-19 severity. Human Molecular Genetics. ISSN: 0964-6906
Trujillo-Del Río C, Tortajada-Pérez J, Gómez-Escribano AP, Casterá F, Peiró C, Millán JM, Herrero MJ, Vázquez-Manrique RP. (2022) Metformin to treat Huntington disease: A pleiotropic drug against a multi-system disorder. Mechanisms of Ageing and Development. ISSN: 0047-6374
Pinto-Merino Á, Labrador J, Zubiaur P, Alcaraz R, Herrero MJ, Montesinos P, Abad-Santos F, Saiz-Rodríguez M. (2022) Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives. Pharmaceutics. ISSN: 1999-4923
García-Alfonso P, Saiz-Rodríguez M, Mondéjar R, Salazar J, Páez D, Borobia AM, Safont MJ, García-García I, Colomer R, García-González X, Herrero MJ, López-Fernández LA, Abad-Santos F. (2022) Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines. Clinical & Translational Oncology. ISSN: 1699-048X
Sendra,L; Olivera,G; Lopez-Andujar,R; Serrano,C; Rojas,L.E; Montalvá ,E.M; Herrero, M.J; Aliño,S; (2022) Pharmacogene Variants associated with liver transplant in a twelve- year clinical follow-up. Pharmaceutics, 23(5839) . ISSN: 1999-4923
Fernández-Delgado, M; Sendra, L; Herrero, Mª ; Olivera-Pasquini, G; Batista-Duharte, A; Aliño, S (2022) Study Of oligonucleotides access and distribution in human peripheral blood mononuclear cells. International Journal Of Molecular Sciences, 23, pp. 1 - 15 . ISSN: 1661-6596
COVID-19 Host Genetics Initiative (SCOURGE group) (2023) A second update on mapping the human genetic architecture of COVID-19. Nature. ISSN: 0028-0836
Castro-Santos P, Rojas-Martinez A, Riancho JA, Lapunzina P, Flores C, Carracedo Á, Díaz-Peña R; Scourge Cohort Group (2023) HLA-A*11:01 and HLA-C*04:01 are associated with severe COVID-19. Hla. ISSN: 2059-2302
Alemany-Navarro M, Diz-de Almeida S, Cruz R, Riancho JA, Rojas-Martínez A, Lapunzina P, Flores C; Scourge Cohort Group; Carracedo A (2023) Psychiatric polygenic risk as a predictor of COVID-19 risk and severity: insight into the genetic overlap between schizophrenia and COVID-19. Translational Psychiatry. ISSN: 2158-3188
Pairo-Castineira E, Rawlik K, Bretherick AD, Qi T, Wu Y, Nassiri I, McConkey GA, Zechner M, Klaric L, Griffiths F, Oosthuyzen W, Kousathanas A, Richmond A, Millar J, Russell CD, Malinauskas T, Thwaites R, Morrice K, Keating S, Maslove D, Nichol A, Semple MG, Knight J, Shankar-Hari M, Summers C, Hinds C, Horby P, Ling L, McAuley D, Montgomery H, Openshaw PJM, Begg C, Walsh T, Tenesa A, Flores C, Riancho JA, Rojas-Martinez A, Lapunzina P; GenOMICC Investigators; SCOURGE Consortium; ISARICC Investigators; 23andMe COVID-19 Team; Yang J, Ponting CP, Wilson JF, Vitart V, Abedalthagafi M, Luchessi AD, Parra EJ, Cruz R, Carracedo A, Fawkes A, Murphy L, Rowan K, Pereira AC, Law A, Fairfax B, Hendry SC, Baillie JK. (2023) GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19. Nature. ISSN: 0028-0836
Agulló L, Muriel J, Margarit C, Escorial M, Garcia D, Herrero MJ, Hervás D, Sandoval J, Peiró AM (2023) Sex Differences in Opioid Response Linked to OPRM1 and COMT genes DNA Methylation/Genotypes Changes in Patients with Chronic Pain. Journal Of Clinical Medicine. ISSN: 2077-0383
Urtasun, A.; Olivera, G.G.; Sendra, L.; Aliño, S.F.; Berlanga, P.; Gargallo, P.; Hervás, D.; Balaguer, J.; Juan-Ribelles, A.; Andrés, M.M.; Cañete, A.; Herrero, M.J. (2023) Personalized medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy. Cancers, 2023(15) . ISSN: 2072-6694

Participacions a Congressos

Olivera,G;Yañez,Y;Herrero,M.J;Berlanga,P;Gargallo,P;Sendra,L;Hervás,D;Font de Mora,J;Segura,V; Ramal,D;Fernández-Delgado,R;Castel,V; Cañete,A;Aliño,S.F (2019). Predictive Polymorphisms of the efficacy of the induction chemotherapy treatment in neuroblastoma. (Poster). 5th ESPT Congress on precision medicine and personalised health . Sevilla . ESPANYA
Olivera,G;Yáñez,Y;Herrero M.J;Berlanga,P; Gargallo,P;Sendra,L;Hervás,D; Font de Mora,J;Segura,V; Ramal,D; Fernández-Delgado,R;Castel,V;Cañete,A;Aliño,S.F. (2019). Polimorfismo Predictivos de la eficacia del tramatiento quimioterápico de inducción en neuroblatoma. (Poster). Congreso Interdisciplinar en Genética Humana. Del 3 al 5 de Abril de 2019 . Madrid . ESPANYA
Herrero,M:J; Sendra.L; Olivera,G; Cervera,J; Montoro,J;Piñana,J.L; Sanz,J; Montalvá,E; López-Andújar,R; Sales,G; Almenar,L; Hernández,J; Aliño,S.F. (2019). Pilot Study to evaluate the clinical implementation of pharmacogenetic analysis in organ transplantation. (Poster). 5th ESPT Congres on precision medicine and personalised health. Del 16 al 18 de Octubre de 2019 . Sevilla . ESPANYA
Herrero,M.J;Sendra,L;Olivera,G;Cervera,J.V;Montoro,J;Piñana,J.L;Sanz,J;Montalvá,E; López-Andújar,R; Sales,G;Almenar,L;Hernández,J;Aliño,S.F (2019). Estudio Piloto para la evaluación de la implementación clínica de los análisis farmacogenéticos en el trasplante. (Poster). II Congreso Interdisciplinar en Genética Humana. Del 3 al 5 de Abril 2019 . Madrid . ESPANYA
Herrero,M.j;Berlanga,P;Aliño,S.F;Olivera,G;Yáñez,Y;Gargallo,P;Sendra,L; Font de Mora,J;Castel,V; Cañete,A. (2019). Pharmacogenetics in HR NB: Spanish Study. (Ponència invitada). Siopen biology meeting.Del 28 al 29 de Enero 2019. Instituto Curie . Paris . FRANÇA
Daslla,F;Genvigir,V;Campos-Salazar,A;Felipe,C,R; Tedesco H; Osmar Medina,J;Hiroyuki,M; Olivera,G; Herrero,M.J;Aliño, S.F; Dominguez,R (2019). CYP3A5 And ABCB1 polymorphisms influence tracrolimus exposure in brazilian and spanish kidney transplant recipients. (Poster). XX Congreso Farmacéutico de Sào Paulo.Del 10 al 12 de Octubre 2019 . Sao Paulo . BRASIL
Olivera,G;Herrero,M.J;Sendra,L;Aliño,S,F (2019). Farmacogenética de los antineoplásicos: Irinotecan y fluoririmidinas. (Comunicació). III Jornadas Cientificas SEFC.Farmacogenética: Investigación traslacional e implementación en el sistema de salud . ESPANYA
Herrero,M.J;Berlanga,P;Aliño,S.F;Oliver,G;Yáñez,Y;Gargallo,P;Ramal,D;Segura,V;Sendra,L; Font de Mora,J;Castel,V:Cañete,A (2019). Farmacogenética.Reunión anual neuroblastoma. (Ponència invitada). Reunión Anual Neuroblastoma 2019.12 de Marzo 2019 . Valencia . ESPANYA
Sendra L; Herrero MJ ; Olivera Gi;Serrano C; Fuster C; Montalvá EM; López R; Aliño S (2021). Variantes farmacogenéticas como potenciales biomarcadores predictivos asociados a la evolución del trasplante hepático. (Poster). III Congreso Interdisciplinar de Genética Humana, 3-5 de noviembre de 2021 . Valencia . ESPANYA
Olivera G ; Sendra L; Gargallo P; Berlanga P; Martínez de la Fuente G; Garcia D; Yáñez Y; Cañete A; F Aliño S; Herrero MJ. (2021). Análisis epigenético del estado de metilación del promotor de farmacogenes relacionados con la quimioterapia en oncologia pediàtrica. (Poster). III Congreso Interdisciplinar de Genética Humana, 3-5 de noviembre de 2021 . Valencia . ESPANYA

Tesis, tesines i treballs